IN FORCE Advance Authorisation

DGFT Minutes

Reliability

In force — no superseding record on file.

Document text

Manual Case

NCIBIMEET/Dee/202425712 jo7i2/2024 M/s Glenmark Pharmaceuticals Limited HQ F. No. HORPRCAPPLY00000603AM25 Advance Authorization No. and Date No. 0310838214 Dt. 11/09/2020 Subject Request to consider export of same finished product in 2 additional pack size made under 32 shipping bills for Redemption Purpose by considering the wastage at 5 % as fixed by NC.

Decision : The Committee considered the request of firm for additional 2 export items (different pack size) for regularization and closure of the Advance Authorisation No. 0310838214 Dt. 11.09.2020 and on the basis of information provided by the firm, it was decided to add the following two additional export items as under:-

==> picture [452 x 139] intentionally omitted <==

----- Start of picture text ----- No. Clindamycin & Benzoyl] 1 Number Pack Clindamycin — Phosphate | 315 mg/pack Peroxide Gel 1% /5% USP (Pack Size 30 gm) Hydrous Benzoyl! Peroxide | 1575 mg/pack USP Clindamycin & Benzoyl] 1 Number Pack | 3 | Clindamycin Phosphate | 630 mg/pack Peroxide Gel 1% /5% USP (Pack Size 60 gm) 4 | Hydrous Benzoyl Peroxide | 3150 mg/pack USP RA concerned may take further necessary action as per above decision of NC. ----- End of picture text -----

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 8068 --apply.